Cahill Brian Joseph has filed 4 insider transactions across 1 company since January 2024.
Most recent transaction: a grant/award of 3800 shares of EAGLE PHARMACEUTICALS, INC. ($EGRX) on February 27, 2024.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 27, 2024 | EAGLE PHARMACEUTICALS, INC. | $EGRX | Cahill Brian Joseph | CHIEF FINANCIAL OFFICER | A | Common Stock | 3800 | $0.00 | 49,547.0000 | 13,154,599 | 8.31% | 0.03% |
| Feb. 27, 2024 | EAGLE PHARMACEUTICALS, INC. | $EGRX | Cahill Brian Joseph | CHIEF FINANCIAL OFFICER | F | Common Stock | 1589 | $6.44 | 47,958.0000 | 13,154,599 | 3.21% | 0.01% |
| Feb. 2, 2024 | EAGLE PHARMACEUTICALS, INC. | $EGRX | Cahill Brian Joseph | CHIEF FINANCIAL OFFICER | F | Common Stock | 934 | $5.85 | 45,747.0000 | 13,154,599 | 2.00% | 0.01% |
| Jan. 5, 2024 | EAGLE PHARMACEUTICALS, INC. | $EGRX | Cahill Brian Joseph | Chief Financial Officer | F | Common Stock | 735 | $5.13 | 46,681.0000 | 13,154,599 | 1.55% | 0.01% |